Molecules and Cells

Korean Society for Molecular and Cellular Biology (한국분자세포생물학회)
권호 표지

Peroxisome Proliferator-activated Receptor-γ Gene Polymorphisms are not associated with Osteonecrosis of the Femoral Head in the Korean Population

  • Kim, Tae-Ho (Skeletal Diseases Genome Research Center, Kyungpook National University Hospital) ;
  • Hong, Jung Min (Skeletal Diseases Genome Research Center, Kyungpook National University Hospital) ;
  • Park, Eui Kyun (Skeletal Diseases Genome Research Center, Kyungpook National University Hospital) ;
  • Kim, Shin-Yoon (Skeletal Diseases Genome Research Center, Kyungpook National University Hospital)
  • Received : 2007.06.04
  • Accepted : 2007.07.16
  • Published : 2007.12.31
⟨ Previous Next ⟩

Abstract

Osteonecrosis of the femoral head (ONFH) is a multifactorial disease to which certain individuals are more at risk. Altered lipid metabolism is one of the major risk factors for osteonecrosis, especially corticosteroid therapy and alcoholism. Peroxisome Proliferator-Activated Receptor-${\gamma}$ ($PPAR{\gamma}$) plays a crucial role in differentiation of mesenchymal cells to adipocytes, lipid homeostasis, and bone metabolism. To investigate the possible association between $PPAR{\gamma}$ gene variants and susceptibility to ONFH, we genotyped three common polymorphisms (-796A > G, +34C > G[Pro12Ala], and +82466C > T[His477His]) in 448 ONFH patients and 336 control subjects. Genotypes, allele frequencies, and haplotypes of the polymorphisms in the complete set of patients as well as in subgroups by sex or etiology were not significantly different from those in the control group. This suggests that the examined polymorphisms and haplotypes of the $PPAR{\gamma}$ gene are unlikely to be associated with susceptibility to ONFH.

Keywords

Acknowledgement

Supported by : Ministry of Health & Welfare

References

  1. Abu-Shakra, M., Buskila, D., and Shoenfeld, Y. (2003) Osteonecrosis in patients with SLE. Clin. Rev. Allergy Immunol. 25, 13-24 https://doi.org/10.1385/CRIAI:25:1:13
  2. Ali, A. A., Weinstein, R. S., Stewart, S. A., Parfitt, A. M., Manolagas, S. C., et al. (2005) Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology 146, 1226-1235 https://doi.org/10.1210/en.2004-0735
  3. Antoine, H. J., Pall, M., Trader, B. C., Chen, Y. D., Azziz, R., et al. (2007) Genetic variants in peroxisome proliferatoractivated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome. Fertil. Steril. 87, 862-869 https://doi.org/10.1016/j.fertnstert.2006.10.006
  4. Assouline-Dayan, Y., Chang, C., Greenspan, A., Shoenfeld, Y., and Gershwin, M. E. (2002) Pathogenesis and natural history of osteonecrosis. Semin. Arthritis Rheum. 32, 94-124
  5. Atsumi, T. and Kuroki, Y. (1992) Role of impairment of blood supply of the femoral head in the pathogenesis of idiopathic osteonecrosis. Clin. Orthop. Relat. Res. 227, 22-30
  6. Backesjo, C. M., Li, Y., Lindgren, U., and Haldosen, L. A. (2006) Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. J. Bone Miner. Res. 21, 993-1002 https://doi.org/10.1359/jbmr.060415
  7. Bowers, J. R., Dailiana, Z. H., McCarthy, E. F., and Urbaniak, J. R. (2004) Drug therapy increases bone density in osteonecrosis of the femoral head in canines. J. Surg. Orthop. Adv. 13, 210-216
  8. Buzzetti, R., Petrone, A., Caiazzo, A. M., Alemanno, I., Zavarella, S., et al. (2005) PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity. Pediatr. Res. 57, 138-140 https://doi.org/10.1203/01.PDR.0000147728.62185.21
  9. Cui, Q., Wang, G. J., Su, C. C., and Balian, G. (1997) The Otto Aufranc Award. Lovastatin prevents steroid induced adipogenesis and osteonecrosis. Clin. Orthop. Relat. Res. 344, 8-19
  10. de Camargo, F. P., de Godoy, R. M., Jr., and Tovo, R. (1984) Angiography in Perthes' disease. Clin. Orthop. Relat. Res. 191, 216-220
  11. Deeb, S. S., Fajas, L., Nemoto, M., Pihlajamaki, J., Mykkanen, L., et al. (1998) A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet. 20, 284-287 https://doi.org/10.1038/3099
  12. Doney, A. S., Fischer, B., Cecil, J. E., Boylan, K., McGuigan, F. E., et al. (2004) Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes. Diabetologia 47, 555-558 https://doi.org/10.1007/s00125-003-1323-1
  13. Fisher, D. E. (1978) The role of fat embolism in the etiology of corticosteroid-induced avascular necrosis: clinical and experimental results. Clin. Orthop. Relat. Res. 130, 68-80
  14. Gardeniers, J. W. M. (1993) The ARCO perspective for reaching one uniform staging system of osteonecrosis; in Bone Circulation and Vascularization in Normal and Pathologic Conditions, Scoutens, A., Arlet, J., Gardeniers, J. W. M., and Hughes, S. P. F. (eds.), pp. 375-n380, Plenum Press, New York.
  15. Glueck, C. J., Freiberg, R. A., and Wang, P. (2003) Role of thrombosis in osteonecrosis. Curr. Hematol. Rep. 2, 417-4422
  16. Hedrick, P. W. (1987) Gametic disequilibrium measures: proceed with caution. Genetics 117, 331-341
  17. Ishida, Y. and Heersche, J. N. (1998) Glucocorticoid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation. J. Bone Miner. Res. 13, 1822-1826 https://doi.org/10.1359/jbmr.1998.13.12.1822
  18. Jaziri, R., Lobbens, S., Aubert, R., Pean, F., Lahmidi, S., et al. (2006) The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the data from an epidemiological study on the insulin resistance syndrome (DESIR) study. Diabetes 55, 1157-1162 https://doi.org/10.2337/diabetes.55.04.06.db05-0676
  19. Jones, J. P., Jr. (1992) Intravascular coagulation and osteonecrosis. Clin. Orthop. Relat. Res. 277, 41-453
  20. Jones, J. P., Jr. (1993) Fat embolism, intravascular coagulation, and osteonecrosis. Clin. Orthop. Relat. Res. 292, 294-2308
  21. Jones, L. C., Mont, M. A., Le, T. B., Petri, M., Hungerford, D. S., et al. (2003) Procoagulants and osteonecrosis. J. Rheumatol. 30, 783-791
  22. Kerachian, M., Harvey, E., Cournoyer, D., Chow, T., and Seguin, C. (2006) Avascular necrosis of the femoral head: vascular hypotheses. Endothelium 13, 237-2244 https://doi.org/10.1080/10623320600904211
  23. Kersten, S., Desvergne, B., and Wahli, W. (2000) Roles of PPARs in health and disease. Nature 405, 421-4424 https://doi.org/10.1038/35013000
  24. Knoblauch, H., Busjahn, A., Muller-Myhsok, B., Faulhaber, H. D., Schuster, H., et al. (1999) Peroxisome proliferator-activated receptor gamma gene locus is related to body mass index and lipid values in healthy nonobese subjects. Arterioscler. Thromb. Vasc. Biol. 19, 2940-2944 https://doi.org/10.1161/01.ATV.19.12.2940
  25. Koo, K. H., Kim, R., Kim, Y. S., Ahn, I. O., Cho, S. H., et al. (2002) Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment. Clin. Rheumatol. 21, 299-303 https://doi.org/10.1007/s100670200078
  26. Liu, Y. F., Chen, W. M., Lin, Y. F., Yang, R. C., Lin, M. W., et al. (2005) Type II collagen gene variants and inherited osteonecrosis of the femoral head. N. Engl. J. Med. 352, 2294-2301 https://doi.org/10.1056/NEJMoa042480
  27. Margeli, A., Kouraklis, G., and Theocharis, S. (2003) Peroxisome proliferator activated receptor-gamma (PPAR-gamma) ligands and angiogenesis. Angiogenesis 6, 165-169 https://doi.org/10.1023/B:AGEN.0000021377.13669.c0
  28. Matsui, M., Saito, S., Ohzono, K., Sugano, N., Saito, M., et al. (1992) Experimental steroid-induced osteonecrosis in adult rabbits with hypersensitivity vasculitis. Clin. Orthop. Relat. Res. 277, 61-72
  29. Meirhaeghe, A., Fajas, L., Helbecque, N., Cottel, D., Lebel, P., et al. (1998) A genetic polymorphism of the peroxisome proliferatoractivated receptor gamma gene influences plasma leptin levels in obese humans. Hum. Mol. Genet. 7, 435-440 https://doi.org/10.1093/hmg/7.3.435
  30. Nuttall, M. E., Patton, A. J., Olivera, D. L., Nadeau, D. P., and Gowen, M. (1998) Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders. J. Bone Miner. Res. 13, 371-382 https://doi.org/10.1359/jbmr.1998.13.3.371
  31. Ogawa, S., Urano, T., Hosoi, T., Miyao, M., Hoshino, S., et al. (1999) Association of bone mineral density with a polymorphism of the peroxisome proliferator-activated receptor gamma gene: PPARgamma expression in osteoblasts. Biochem. Biophys. Res. Commun. 260, 122-126 https://doi.org/10.1006/bbrc.1999.0896
  32. Pritchett, J. W. (2001) Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin. Orthop. Relat. Res. 386, 173-178 https://doi.org/10.1097/00003086-200105000-00022
  33. Qin, Z. S., Niu, T., and Liu, J. S. (2002) Partition-ligationexpectation- maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am. J. Hum. Genet. 71, 1242-1247 https://doi.org/10.1086/344207
  34. Rosen, C. J. and Bouxsein, M. L. (2006) Mechanisms of disease: is osteoporosis the obesity of bone? Nat. Clin. Pract. Rheumatol. 2, 35-43 https://doi.org/10.1038/ncprheum0070
  35. Rosen, E. D. and Spiegelman, B. M. (2001) PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem. 276, 37731-37734 https://doi.org/10.1074/jbc.R100034200
  36. Takano, H. and Komuro, I. (2002) Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease. J. Diabetes Complications 16, 108-114 https://doi.org/10.1016/S1056-8727(01)00203-3
  37. Wang, G. J., Sweet, D. E., Reger, S. I., and Thompson, R. C. (1977) Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits. J. Bone Joint. Surg. Am. 59, 729-7735 https://doi.org/10.2106/00004623-197759060-00003
  38. Wang, Y., Li, Y., Mao, K., Li, J., Cui, Q., et al. (2003) Alcoholinduced adipogenesis in bone and marrow: a possible mechanism for osteonecrosis. Clin. Orthop. Relat. Res. 410, 213-224 https://doi.org/10.1097/01.blo.0000063602.67412.83
  39. Yki-Jarvinen, H. (2004) Thiazolidinediones. N. Engl. J. Med. 351, 1106-1118 https://doi.org/10.1056/NEJMra041001
  40. Zizic, T. M., Marcoux, C., Hungerford, D. S., Dansereau, J. V., and Stevens, M. B. (1985) Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am. J. Med. 79, 596-604 https://doi.org/10.1016/0002-9343(85)90057-9